- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Zimbabwe’s Marange Diamonds Attract “Much Interest” in Antwerp
Bloomberg reported that Zimbabwe’s first auction of diamonds from its Eastern Marange fields following the European Union’s removal of sanctions has drawn “much interest,” as per the Antwerp World Diamond Centre. The prices fetched by the gems are, however, confidential.
Bloomberg reported that Zimbabwe’s first auction of diamonds from its Eastern Marange fields following the European Union’s removal of sanctions has drawn “much interest,” as per the Antwerp World Diamond Centre. The prices fetched by the gems are, however, confidential.
As quoted in the market news:
The EU in September ended sanctions on the sale of diamonds originating from Zimbabwe’s Marange fields. Advocacy groups including Ontario-based Partnership Africa Canada have accused President Robert Mugabe’s ruling party of taking about $2 billion from the fields. The government has denied any misuse of funds.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.